Veeco Instruments Inc. (VECO) | The Buildout — AI Infrastructure
The Verdict
Veeco builds specialty semiconductor process equipment that solves materials engineering problems across multiple AI-infrastructure choke points: laser annealing and ion beam systems for leading-edge logic and memory, wet processing and lithography for advanced packaging, and MOCVD and ion beam deposition for silicon photonics and indium-phosphide lasers. Its tools are used where AI accelerators, high-bandwidth memory, and optical interconnects are manufactured, making the company a cross-cutting supplier rather than a single-product bet.
| Market Cap | — |
| Revenue (TTM) | $655M |
| Revenue Growth | −7.7% |
| EBITDA Margin (TTM) | 7.3% |
| Net Cash | $122M |
| Earnings Beats | 5 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- $250M+ InP laser tool orders in Q1 2026 across MOCVD, wet processing, and ion beam deposition, with deliveries starting Q3 2026 and ramping Q1 2027.
- $200M advanced packaging orders in Q2 2026 for wet processing and lithography, principally 2027 delivery.
- LSA is production tool of record at all three Tier 1 logic customers, and NSA is now engaged with all three after a Tier 1 follow-on order.
- Customer deposits climbed $45M sequentially to $114M in Q2, a cash indicator of committed demand.
- Management says a significant portion of anticipated 2027 revenue is already in backlog, and customers are sharing forecasts beyond 2027.
What We’re Watching
- China BIS/regulatory risk: Q1 2026 had an $8M LSA revenue hit, and China rose to 25% of Q2 revenue; the Axcelis merger still needs China antitrust approval for the targeted 2H 2026 close.
- Capacity execution: SPECTOR IBD capacity is planned to increase about 10x by early 2027, and advanced packaging/silicon photonics capacity more than doubles in 2027; if the 2027 ramp slips, the ~$10M incremental OpEx and ~75 bps gross margin impact in 2026 are unrewarded.
- Memory IBD300 evaluations continue through 2026; management cites remaining work on particle performance, automation, and reliability before production orders.
- NSA second evaluation sign-off: the prior expectation of two evaluations signed off during 2026 was not clearly reaffirmed; Q2 reported one completed evaluation with a follow-on order.
The thesis is strengthening on the order and backlog evidence: two large order blocks landed in consecutive quarters, customer deposits jumped, and management says a significant portion of 2027 revenue is already in backlog. The offset is that the company is deliberately compressing near-term earnings to build capacity, and a couple of earlier targets — a second NSA evaluation sign-off and a 45% gross margin in 2H 2026 — went unaddressed. The open question is whether the 2027 revenue ramp materializes on schedule to absorb the capacity investment.
Earnings Beat
Veeco reported Q2 2026 revenue of $193.5 million, up from $166.1 million a year earlier. Non-GAAP gross margin was 39.5%. The quarter included $200 million in advanced packaging orders for wet processing and lithography systems, principally for 2027 delivery.
| Metric | Q1 FY2026 | Q4 FY2025 | Q1 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $158M | $165M | $167M | −5.4% |
| Gross margin | 34.8% | 37.1% | 40.9% | -610bps |
| EBITDA | $6M | $9M | $19M | −67.2% |
| EPS | $-0.00 | $0.02 | $0.20 | −102.5% |
| Customer deposits | $114M | $69M | n/a | — |
We believe the industry is at an important inflection point where AI-driven investments are accelerating demand for enabling semiconductor technologies at an unprecedented pace.— Bill Miller, Chief Executive Officer, August 5, 2026
Management tone: Management's tone shifted from describing an inflection to describing deliberate investment ahead of revenue. The prepared remarks were dense with product and customer statuses, while the Q&A was thin, with only one analyst questioner recorded in the transcript.
Management Guidance
For Q3 2026, management guided revenue of $200–220 million, gross margin of 41–42%, operating expenses of $57–58 million, net income of $23–33 million, and diluted EPS of $0.35–0.49 on roughly 67 million shares. For full-year 2026, revenue guidance was raised to $780–810 million, gross margin set at 40–42%, operating expenses at $215–225 million, and non-GAAP EPS cut to $1.36–1.61. The company attributed the margin and EPS effects to roughly $10 million of incremental operating expense and about 75 basis points of gross margin impact from capacity expansion, hiring, training, contract-manufacturer onboarding, and supply-chain expansion.
Trajectory
The trailing audited quarters show stable revenue with a recent dip: $166.1 million in Q2 FY2025 to $158.3 million in Q1 FY2026, while GAAP gross margin compressed from 41.4% to 34.8%. The company's Q2 2026 call reported revenue of $193.5 million and non-GAAP gross margin of 39.5%. Code-computed signals show stable revenue trajectory and compressing margins on a trailing basis, with free cash flow conversion strong at 186% of net income. The Q2 step-up is driven by advanced packaging, data storage, and annealing strength, while the margin recovery is tempered by the roughly 75-basis-point impact of growth investments.
The Model
The model projects FY+1 revenue of $788 million and EBITDA of $151 million, a 19.1% EBITDA margin. FY+2 projections step up to $980 million in revenue and $230 million in EBITDA, a 23.5% margin. Near-term revenue is anchored by the raised FY2026 guidance of $780–810 million and management's statement that a significant portion of 2027 revenue is already in backlog. The FY+2 driver is the 2027 capacity expansion in advanced packaging and silicon photonics, with model dispersion on FY+2 revenue spanning $945 million to $1,085 million.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $664M | $788M | $980M |
| YoY Growth | — | +18.6% | +24.4% |
| EBITDA | $61M | $151M | $230M |
| EBITDA Margin | 9.2% | 19.1% | 23.5% |
Projections are the median of 5 independent model runs. The model’s revenue sits 7.8% below analyst consensus.
For Q3 2026, management guided revenue of $200–220 million, gross margin of 41–42%, operating expenses of $57–58 million, net income of $23–33 million, and diluted EPS of $0.35–0.49 on roughly 67 million shares. For full-year 2026, revenue guidance was raised to $780–810 million, gross margin set at 40–42%, operating expenses at $215–225 million, and non-GAAP EPS cut to $1.36–1.61. The company attributed the margin and EPS effects to roughly $10 million of incremental operating expense and about 75 basis points of gross margin impact from capacity expansion, hiring, training, contract-manufacturer onboarding, and supply-chain expansion.
What Could Go Right — and Wrong
- InP laser orders convert on schedule: shipments start Q3 2026, with the most significant ramp beginning Q1 2027.
- Advanced packaging $200 million Q2 order block translates to 2027 revenue as planned and draws repeat orders.
- NSA follow-on orders expand: a second Tier 1 evaluation sign-off and production adoption could broaden annealing revenue.
- Memory IBD300 evaluations convert to high-volume manufacturing orders after the engineering work on particle performance and reliability is completed.
- Panel-level packaging engagement with a Tier 1 foundry becomes an order, expanding the advanced packaging SAM.
- 2027 ramp slips: if the Q4 2026–Q2 2027 shipment phasing is delayed, 2026 capacity costs are unrewarded.
- China regulatory setback: further BIS actions or a delayed China antitrust approval for the Axcelis merger could hit shipments or the deal timeline.
- Competitor displacement in advanced packaging or photonics: Aixtron in InP epitaxy or Applied Materials in packaging could win next-node business.
- Gross margin stays in the low-40s instead of rebuilding toward the prior 45% ambition, muting the 2027 profit rebound.
- Downstream OSAT pushouts (Amkor's $50–100 million per quarter customer material pushouts) migrate upstream and delay tool deliveries.
Looking Ahead
The next twelve months hinge on the conversion of order backlog into revenue. InP laser tool shipments start in Q3 2026, with the most significant ramp beginning Q1 2027; advanced packaging orders are principally for 2027 delivery. The company plans to more than double advanced packaging and silicon photonics capacity during 2027 while closing the Axcelis merger in the second half of 2026 pending China antitrust approval. Memory IBD300 evaluations continue through 2026, with potential production orders in 2027.
- Q3 2026InP laser shipments begin — First shipments against $250M+ InP orders; tests ramp start.
- Q3 2026Q3 earnings report — Checks $200–220M revenue and 41–42% gross margin guidance.
- 2H 2026NSA second system ships — Follow-on NSA system to ship to Tier 1 logic customer.
- End 2026GaN Propel pilot line — Leading power IDM pilot-line tool ships around end of 2026.
- 2H 2026Axcelis merger close — Pending China antitrust approval; targets second half 2026 close.
- Early 2027SPECTOR capacity step-up — SPECTOR IBD capacity about 10x from base, starting early 2027.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $717M | $664M | $655M | -7.4% |
| Gross Margin | 42.4% | 39.9% | 38.4% | 248bps |
| EBITDA | $92M | $61M | −$5M | -33.9% |
| EBITDA Margin | 12.8% | 9.2% | 7.3% | 367bps |
| Net Income | $74M | $35M | $23M | -52.2% |
| Free Cash Flow | $46M | $53M | $212M | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)38.4%
- EBITDA Margin (TTM)7.3%
- Net Margin (TTM)3.5%
- ROIC2.4%
- FCF Conversion89.4%
- SBC / Revenue4.2%
The Company
Veeco builds specialty semiconductor process equipment that solves materials engineering problems for chip, photonics, storage, and research customers. Its technologies include ion beam deposition and etch, laser annealing, MOCVD, CVD, advanced packaging lithography, single-wafer wet processing, MBE, and ALD. The company reports four end-market views: Semiconductor, Compound Semiconductor, Data Storage, and Scientific & Other, with key products such as LSA, NSA, IBD300, SPECTOR, and Lumina MOCVD.
Veeco operates eight facilities across New York, New Jersey, Minnesota, California, Pennsylvania, and Massachusetts, with R&D, manufacturing, sales, and administration co-located at several sites. It builds some products internally on the East Coast and is expanding capacity for 2027 through internal manufacturing and outsourced contract manufacturing in Southeast Asia. As of Q2 2026, the company reported cash and short-term investments of $429 million and inventory of $292 million.
Business Segments
Competitive Landscape
Veeco's competitive position varies by product line. It describes itself as a market leader in ion beam deposition for EUV mask blanks and a strong incumbent in indium-phosphide laser facet coating, but more of a second source in MOCVD epitaxy. In laser annealing, LSA is the production tool of record at all three Tier 1 logic customers. Applied Materials is named as a competitor, alongside Aixtron, Canon, Screen Semiconductor Solutions, and Mattson Technology, among others in the 10-K list.
- AixtronNamed in the 10-K competitor list.
- Applied MaterialsNamed in the 10-K competitor list.
- CanonNamed in the 10-K competitor list.
- Screen Semiconductor SolutionsNamed in the 10-K competitor list.
- Mattson TechnologyNamed in the 10-K competitor list.
Supply Chain
Veeco sits between component suppliers and chip, photonics, and storage manufacturers, supplying deposition, etch, annealing, and wet-processing tools. The source labels most supplier and customer tickers as inferred ecosystem neighbors, not confirmed Veeco disclosures.
More on VECO: Earnings recap